Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|October 2, 2019
[Cognitive ability to mental disorders among medical workers in ear-nose-throat departments and its impact on doctor-patient relationship]Yutong Tu, Yuyu Chou, Bangshan Liu, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Design, Synthesis, and Structure-Activity Relationship Studies of 7H‑Pyrrolo[2,3‑d]pyrimidine Derivatives as Potent Casein Kinase 1α (CK1α) InhibitorsMeiying Liu, Yutong Tu, Wangyang Xu, et al.
Bioorganic Chemistry|February 18, 2024
Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteinsQian Yu, Zheng Wang, Yutong Tu, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Design, Synthesis, and Biological Evaluation of 2,4-Diaminopyrimidine Derivatives as Potent CDK7 InhibitorsHualin Zhang, Yutong Tu, Zhaofan Tao, et al.
European Journal of Medicinal Chemistry|February 26, 2022
Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatmentYu Cao, Yutong Tu, Liping Fu, et al.
Leukemia|March 26, 2026
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicityYutong Tu, Xiaojia Cai, Zhaofan Tao, et al.
Nature Communications|April 5, 2023
Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemiaHanlin Wang, Guanghao Luo, Xiaobei Hu, et al.
Leukemia|December 16, 2022
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemiaKailong Jiang, Xuemei Li, Chang Wang, et al.
Pageof 1